Merkel Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Merkel Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors [Phase 2]
ClinicalTrials.gov update for QUILT-3.055, a Phase 2 study of combination immunotherapies in patients who previously received immune checkpo…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery [Phase 2]
A Phase 2 clinical trial is evaluating a chemo-immunotherapy regimen in patients with resectable Merkel cell carcinoma before surgical resec…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating in situ immunomodulation using CDX-301, CDX-1140, and Poly-ICLC with radiation therapy in patients with unresecta…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
A clinical trial update announcing a liquid biomarker study in melanoma and non-melanoma skin cancers that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma
The clinical trial update reports validation of an in vitro method for anti-MCPyV immunotherapy in patients with cutaneous Merkel cell carci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus [Phase 2]
Phase 2 trial evaluating autologous cytotoxic T lymphocytes for BK virus and JC virus infections in immunocompromised patients (including AI…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC) [Phase 1]
A Phase 1 clinical trial evaluating IFx-Hu2.0 as an adjunct to pembrolizumab in advanced or metastatic Merkel cell carcinoma is currently re…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Personalised Immunotherapy Platform
Clinical trial update for a personalised immunotherapy platform; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma [Phase 1]
This is a Phase 1 trial update for FF-10850 liposome-encapsulated topotecan in advanced solid tumors, including Merkel cell carcinoma; the s…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 study of MEM-288 oncolytic virus in advanced solid tumors, evaluating MEM-288 alone and in combination with standard-of-care therapy…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Beta-only IL-2 ImmunoTherapY Study [Phase 1, Phase 2]
Medicennа Therapeutics is evaluating a beta-only IL-2 immunotherapy (MDNA11) in Phase 1/2 across multiple advanced solid tumors; recruitment…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: DOTATOC PET/CT for Imaging NET Patients
ClinicalTrials.gov entry describes a DOTATOC PET/CT imaging study for neuroendocrine tumors, sponsored by the British Columbia Cancer Agency…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO [Phase 3]
A Phase 3 trial is evaluating whether an immune-oncology therapy given every three months after six months of standard administration is as …
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers
Clinical trial update indicating recruitment for a study on sentinel lymph node biopsy in ocular surface and adnexal cancers.
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: IFx-Hu2.0 Expanded Access Program
TuHURA Biosciences reports that the IFx-Hu2.0 Expanded Access Program is available for patients with cutaneous melanoma (Stage III/IV), Merk…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies [Phase 2]
Phase 2 trial update for Zirconium-89 labeled Crefmirlimab Berdoxam PET/CT in advanced or metastatic cancers; the study is currently active …
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma
A clinical trial evaluating circulating tumor cells before and after surgery and radiotherapy in patients with resectable stage I-III Merkel…
-
CLINICAL_TRIALS research · 2018-05-08Clinical Trial Update: Epidemiology of Merkel Carcinomas in the Bas-Rhin
This clinical trial update reports on the epidemiology of Merkel cell carcinoma in the Bas-Rhin region of France.